Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7008)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Aug 15, 2021 (publication date) through Jan 29, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Weingarden AR, Rubin SJS, Gubatan J. Immune checkpoint inhibitor-mediated colitis in gastrointestinal malignancies and inflammatory bowel disease. World J Gastrointest Oncol 2021; 13(8): 772-798 [PMID: 34457186 DOI: 10.4251/wjgo.v13.i8.772] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i8/772.htm |
| Number | Citing Articles |
| 1 |
Tuan Tran, Nguyen Giang Tien Tran, Vincent Ho. Checkpoint Inhibitors and the Gut. Journal of Clinical Medicine 2022; 11(3): 824 doi: 10.3390/jcm11030824
|
| 2 |
Aaron Lerner, Carina Benzvi. Checkpoint Inhibitors and Induction of Celiac Disease-like Condition. Biomedicines 2022; 10(3): 609 doi: 10.3390/biomedicines10030609
|
| 3 |
Simon-Johannes Lott, Michael Meiborg. Colitis ulcerosa-assoziiert oder hereditäre Genese?. Gastro-News 2023; 10(1): 6 doi: 10.1007/s15036-022-3181-z
|
| 4 |
Sara Kiparizoska, Megan E. Murphy, Mark C. Mattar. Check this out: treatment paradigms in immune-checkpoint inhibitor colitis. Current Opinion in Gastroenterology 2023; 39(1): 43 doi: 10.1097/MOG.0000000000000892
|
| 5 |
Samantha Sharma, Naresh Singh, Anita Ahmed Turk, Isabella Wan, Akshay Guttikonda, Julia Lily Dong, Xinna Zhang, Mateusz Opyrchal. Molecular insights into clinical trials for immune checkpoint inhibitors in colorectal cancer: Unravelling challenges and future directions. World Journal of Gastroenterology 2024; 30(13): 1815-1835 doi: 10.3748/wjg.v30.i13.1815
|
| 6 |
Sigrun Grimsdottir, Mohamed Attauabi, Emilie Kristine Dahl, Johan Burisch, Jakob Benedict Seidelin. Systematic Review with Meta-analysis: The Impact of Cancer Treatments on the Disease Activity of Inflammatory Bowel Diseases. Journal of Crohn's and Colitis 2023; 17(7): 1139 doi: 10.1093/ecco-jcc/jjad010
|
| 7 |
Alexander R. Moschen, Yossi Sammy, Zoe Marjenberg, Amy B. Heptinstall, Nick Pooley, Agnieszka M. Marczewska. The Underestimated and Overlooked Burden of Diarrhea and Constipation in Cancer Patients. Current Oncology Reports 2022; 24(7): 861 doi: 10.1007/s11912-022-01267-3
|
| 8 |
Tsvetelina Velikova, Boris Krastev, Milena Gulinac, Miroslav Zashev, Vasko Graklanov, Milena Peruhova. New strategies in the diagnosis and treatment of immune-checkpoint inhibitor-mediated colitis. World Journal of Clinical Cases 2024; 12(6): 1050-1062 doi: 10.12998/wjcc.v12.i6.1050
Abstract(403) |
Core Tip(356) |
Full Article(HTML)(1561)
|
Full Article with Cover (PDF)-6262K(138)
|
Full Article (Word)-2309K(14)
|
Audio-266K(3)
|
Peer-Review Report-321K(34)
|
Answering Reviewers-199K(59)
|
Supplementary Material-160K(39)
|
Full Article (PDF)-6032K(105)
|
Full Article (XML)-184K(44)
|
Times Cited (0)
|
Total Visits (4035)
|
Open
|
| 9 |
Ngozi Y. Enwerem, Eugene F. Yen. The colitis may be microscopic, but the diarrhea is not: update on the treatment of microscopic colitis and immune checkpoint inhibitor colitis. Current Opinion in Gastroenterology 2024; 40(1): 50 doi: 10.1097/MOG.0000000000000986
|
| 10 |
Meher Afroz, Md. Shimul Bhuia, Md. Anisur Rahman, Rubel Hasan, Tawhida Islam, Md. Rakibul Islam, Raihan Chowdhury, Md. Ali Khan, Davi Antas e Silva, Henrique Douglas Melo Coutinho, Muhammad Torequl Islam. Anti-diarrheal effect of piperine possibly through the interaction with inflammation inducing enzymes: In vivo and in silico studies. European Journal of Pharmacology 2024; 965: 176289 doi: 10.1016/j.ejphar.2023.176289
|
| 11 |
Seong Ran Jeon. The Impact of Cancer Treatments on the Disease Activity of Inflammatory Bowel Diseases. The Korean Journal of Gastroenterology 2023; 81(3): 142 doi: 10.4166/kjg.2023.025
|
| 12 |
Charit Tippareddy, Orlando M. Martinez, Andrew R. Benza, Kaustav Bera, Nikhil Ramaiya, Sree Harsha Tirumani. From guidelines to radiology practice: navigating the 2023 ASCO guidelines for advanced gastroesophageal cancer and beyond. Abdominal Radiology 2024; 50(1): 78 doi: 10.1007/s00261-024-04499-y
|
| 13 |
Wenyi Li, Zhaokun Wu, Weidong Meng, Chaoting Zhang, Mingzhen Cheng, Yuehong Chen, Yini Zou, Kejun Li, Simin Lin, Wenjun Xiong, Ying Wang, Yixiong Lin, Wenhui Ma, Weijie Zhou. Blockade of IL-6 inhibits tumor immune evasion and improves anti–PD-1 immunotherapy. Cytokine 2022; 158: 155976 doi: 10.1016/j.cyto.2022.155976
|